121 related articles for article (PubMed ID: 35248879)
1. Generation of a human iPSC line, INMi005-A, from a patient with non-syndromic USH2A-associated retinitis pigmentosa.
Sanjurjo-Soriano C; Erkilic N; Vache C; Dubois G; Roux AF; Meunier I; Kalatzis V
Stem Cell Res; 2022 Apr; 60():102738. PubMed ID: 35248879
[TBL] [Abstract][Full Text] [Related]
2. Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa.
Sanjurjo-Soriano C; Erkilic N; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
Stem Cell Res; 2018 Dec; 33():228-232. PubMed ID: 30453153
[TBL] [Abstract][Full Text] [Related]
3. Generation of two human induced pluripotent stem cell lines from patients with biallelic USH2A variants.
Zhu T; Wu S; Sun Z; Wei X; Han X; Zou X; Sui R
Stem Cell Res; 2021 Aug; 55():102502. PubMed ID: 34419747
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene.
Riera M; Patel A; Corcostegui B; Chang S; Corneo B; Sparrow JR; Pomares E
Stem Cell Res; 2019 Mar; 35():101386. PubMed ID: 30685615
[TBL] [Abstract][Full Text] [Related]
5. Generation of a human iPSC line, INMi002-A, carrying the most prevalent USH2A variant associated with Usher syndrome type 2.
Sanjurjo-Soriano C; Erkilic N; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
Stem Cell Res; 2018 Dec; 33():247-250. PubMed ID: 30468996
[TBL] [Abstract][Full Text] [Related]
6. Identification of 13 novel USH2A mutations in Chinese retinitis pigmentosa and Usher syndrome patients by targeted next-generation sequencing.
Qu LH; Jin X; Long YL; Ren JY; Weng CH; Xu HW; Liu Y; Meng XH; Li SY; Yin ZQ
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31904091
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a human iPSC line, IISHDOi004-A, from a patient with Usher syndrome associated with the mutation c.2276G>T; p.Cys759Phe in the USH2A gene.
Zurita-Díaz F; Ortuño-Costela MDC; Moreno-Izquierdo A; Galbis L; Millán JM; Ayuso C; Garesse R; Gallardo ME
Stem Cell Res; 2018 Aug; 31():152-156. PubMed ID: 30096711
[TBL] [Abstract][Full Text] [Related]
8. Mutation screening of the USH2A gene in retinitis pigmentosa and USHER patients in a Han Chinese population.
Huang L; Mao Y; Yang J; Li Y; Li Y; Yang Z
Eye (Lond); 2018 Oct; 32(10):1608-1614. PubMed ID: 29899460
[TBL] [Abstract][Full Text] [Related]
9. Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene.
McLenachan S; Wong EYM; Zhang X; Leith F; Moon SY; Zhang D; Chen SC; Thompson JA; McLaren T; Lamey T; De Roach JN; Atlas MD; Dilley RJ; Chen FK
Stem Cell Res; 2019 Apr; 36():101420. PubMed ID: 30904819
[TBL] [Abstract][Full Text] [Related]
10.
Sanjurjo-Soriano C; Jimenez-Medina C; Erkilic N; Cappellino L; Lefevre A; Nagel-Wolfrum K; Wolfrum U; Van Wijk E; Roux AF; Meunier I; Kalatzis V
HGG Adv; 2023 Oct; 4(4):100229. PubMed ID: 37654703
[TBL] [Abstract][Full Text] [Related]
11. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
[TBL] [Abstract][Full Text] [Related]
12. Visual Outcomes in Japanese Patients with Retinitis Pigmentosa and Usher Syndrome Caused by USH2A Mutations.
Nagase Y; Kurata K; Hosono K; Suto K; Hikoya A; Nakanishi H; Mizuta K; Mineta H; Minoshima S; Hotta Y
Semin Ophthalmol; 2018; 33(4):560-565. PubMed ID: 28678594
[TBL] [Abstract][Full Text] [Related]
13. Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa.
McGee TL; Seyedahmadi BJ; Sweeney MO; Dryja TP; Berson EL
J Med Genet; 2010 Jul; 47(7):499-506. PubMed ID: 20507924
[TBL] [Abstract][Full Text] [Related]
14. Novel USH2A mutations in Israeli patients with retinitis pigmentosa and Usher syndrome type 2.
Kaiserman N; Obolensky A; Banin E; Sharon D
Arch Ophthalmol; 2007 Feb; 125(2):219-24. PubMed ID: 17296898
[TBL] [Abstract][Full Text] [Related]
15. Generation of an iPS cell line via a non-integrative method using urine-derived cells from a patient with USH2A-associated retinitis pigmentosa.
Guo Y; Zeng Q; Liu S; Yu Q; Wang P; Ma H; Shi S; Yan X; Cui Z; Xie M; Xue Y; Zha Q; Li Z; Zhang J; Tang S; Chen J
Stem Cell Res; 2018 May; 29():139-142. PubMed ID: 29660607
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of a human iPSC line (JUFMDOi007-A) from a patient with Usher syndrome due to mutation in USH2A.
Ukaji T; Takahashi-Shibata M; Arai D; Tsutsumi H; Tajima S; Akamatsu W; Matsumoto F; Ikeda K; Usami SI; Kamiya K
Stem Cell Res; 2023 Jun; 69():103100. PubMed ID: 37099934
[TBL] [Abstract][Full Text] [Related]
17.
Zhu T; Chen DF; Wang L; Wu S; Wei X; Li H; Jin ZB; Sui R
Br J Ophthalmol; 2021 May; 105(5):694-703. PubMed ID: 32675063
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations.
Dulla K; Slijkerman R; van Diepen HC; Albert S; Dona M; Beumer W; Turunen JJ; Chan HL; Schulkens IA; Vorthoren L; den Besten C; Buil L; Schmidt I; Miao J; Venselaar H; Zang J; Neuhauss SCF; Peters T; Broekman S; Pennings R; Kremer H; Platenburg G; Adamson P; de Vrieze E; van Wijk E
Mol Ther; 2021 Aug; 29(8):2441-2455. PubMed ID: 33895329
[TBL] [Abstract][Full Text] [Related]
19. Truncating Variants Contribute to Hearing Loss and Severe Retinopathy in
Inaba A; Maeda A; Yoshida A; Kawai K; Hirami Y; Kurimoto Y; Kosugi S; Takahashi M
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105608
[No Abstract] [Full Text] [Related]
20. Spectral-Domain Optical Coherence Tomography Analysis in Syndromic and Nonsyndromic Forms of Retinitis Pigmentosa due to USH2A Genetic Variants.
Colombo L; Maltese PE; Romano D; Fogagnolo P; Castori M; Marceddu G; Cristofoli F; Percio M; Piteková B; Modarelli AM; Bertelli M; Rossetti L
Ophthalmic Res; 2022; 65(2):180-195. PubMed ID: 34781295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
